BTN2A2 Antikörper (AA 33-262)
-
- Target Alle BTN2A2 Antikörper anzeigen
- BTN2A2 (butyrophilin, Subfamily 2, Member A2 (BTN2A2))
-
Bindungsspezifität
- AA 33-262
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BTN2A2 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC), Western Blotting (WB)
- Aufreinigung
- Protein G
- Immunogen
- Recombinant human Butyrophilin subfamily 2 member A2 protein (33-262AA).
- Isotyp
- IgG
- Top Product
- Discover our top product BTN2A2 Primärantikörper
-
anti-butyrophilin, Subfamily 2, Member A2 (BTN2A2) (AA 57-237) antibody
BTN2A2 Reaktivität: Human ELISA, IHC, FACS Wirt: Maus Monoclonal 6C7D2 unconjugated
anti-butyrophilin, Subfamily 2, Member A2 (BTN2A2) (AA 57-237) antibodyBTN2A2 Reaktivität: Human ELISA, WB, FACS, ICC Wirt: Maus Monoclonal 4B11C8 unconjugated
anti-butyrophilin, Subfamily 2, Member A2 (BTN2A2) (AA 33-262) antibodyBTN2A2 Reaktivität: Human ELISA, IHC, WB Wirt: Kaninchen Polyclonal unconjugated
anti-butyrophilin, Subfamily 2, Member A2 (BTN2A2) antibodyBTN2A2 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-butyrophilin, Subfamily 2, Member A2 (BTN2A2) (N-Term) antibodyBTN2A2 Reaktivität: Human, Rind (Kuh), Hund, Meerschweinchen, Pferd, Kaninchen WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 0.01 M PBS, pH 7.4, 0.03 % Proclin-300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Aliquot and store at -20 °C or -80 °C. Avoid repeated freeze/thaw cycles.
-
- Target
- BTN2A2 (butyrophilin, Subfamily 2, Member A2 (BTN2A2))
- Andere Bezeichnung
- BTN2A2 (BTN2A2 Produkte)
- Gen-ID
- 10385
- UniProt
- Q8WVV5
- Pathways
- Activated T Cell Proliferation
-
